Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Goodwill: 2022-2024

Historic Goodwill for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $12.0 million.

  • Axsome Therapeutics' Goodwill changed negligibly% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $12.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of FY2024, Axsome Therapeutics' Goodwill stood at $12.0 million, which was down 0.00% from $12.0 million recorded in FY2023.
  • In the past 5 years, Axsome Therapeutics' Goodwill registered a high of $12.0 million during FY2023, and its lowest value of $10.3 million during FY2022.
  • Over the past 3 years, Axsome Therapeutics' median Goodwill value was $12.0 million (recorded in 2024), while the average stood at $11.5 million.
  • Data for Axsome Therapeutics' Goodwill shows a peak YoY climbed of 16.80% (in 2023) over the last 5 years.
  • Axsome Therapeutics' Goodwill (Yearly) stood at $10.3 million in 2022, then increased by 16.80% to $12.0 million in 2023, then remained steady at $12.0 million in 2024.